Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity.

Nonconvulsive status epilepticus (NCSE) is characterized by behavioral or cognitive change from baseline for at least 30 minutes with EEG evidence of seizures. Categorized into complex partial status epilepticus (with lateralized seizures), and generalized nonconvulsive status epilepticus (bilateral diffuse synchronous seizures), there is debate regarding the diagnosis and morbidity of NCSE. Because EEG is needed for diagnosis, only a high index of suspicion leads to a request for the study, whereas EEG is often unavailable after hours or on weekends. Furthermore, the cognitive changes during NCSE are often incorrectly ascribed to a postictal state, intoxication, psychogenic or psychotic states, and mental retardation. Regarding categorization, present classifications address EEG features but fail to distinguish among depths of coma. Deeply comatose patients (with coma etiologies that themselves carry poor prognoses) are mixed with lightly obtunded patients with no morbidity, confusing the prognosis. Thus, a classification that subsumes depth of coma, and possibly etiology, is sorely warranted. Regarding treatment, comatose NCSE patients treated with benzodiazepines may worsen, whereas generalized nonconvulsive status epilepticus patients may suffer iatrogenically from aggressive treatment (hypotension and respiratory depression) necessitating balancing the potential neurologic morbidity of NCSE against the possible morbidity of IV antiepileptic drugs. A high index of suspicion is needed to initiate EEG studies. Better stratification of level of consciousness will be needed to distinguish among morbidity due to underlying conditions, treatment, and the effects of status epilepticus, proper.

[1]  C. Dodrill,et al.  Intellectual impairment as an outcome of status epilepticus , 1990, Neurology.

[2]  V. Rao,et al.  Extravasation injury to the hand by intravenous phenytoin. Report of three cases. , 1988, Journal of neurosurgery.

[3]  J. Marx,et al.  Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. , 1983, JAMA.

[4]  E. Shanbrom,et al.  Immunodiffusion techniques in clinical medicine. I. Immunoelectrophoresis. , 1967, JAMA.

[5]  A. de Weerd,et al.  Non‐convulsive status epilepticus as cause for focal neurological deficit , 1995, Acta neurologica Scandinavica.

[6]  A. Beaumanoir,et al.  [Confusional states of epileptic origin. Value of emergency EEG]. , 1988, Revue neurologique.

[7]  B. Meldrum,et al.  Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. , 1973, Archives of neurology.

[8]  T. Tomson,et al.  Nonconvulsive Status Epilepticus in Adults: Thirty‐Two Consecutive Patients from a General Hospital Population , 1992, Epilepsia.

[9]  R. Ramsay,et al.  Double-blind study of lorazepam and diazepam in status epilepticus. , 1983, JAMA.

[10]  F. Mcdowell,et al.  The cardiocirculatory changes caused by intravenous Dilantin and its solvent. , 1967, American heart journal.

[11]  C. Heck,et al.  Serum neuron-specific enolase in the major subtypes of status epilepticus , 1999, Neurology.

[12]  D. Treiman,et al.  Subtle generalized convulsive status epilepticus , 1984 .

[13]  R. Sankar,et al.  Pathophysiological Mechanisms of Brain Damage from Status Epilepticus , 1993, Epilepsia.

[14]  M. Granner,et al.  Nonconvulsive Status Epilepticus: EEG Analysis in a Large Series , 1994, Epilepsia.

[15]  D. Hanna.  Purple Glove Syndrome: A Complication of Intravenous Phenytoin , 1992, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[16]  R. Krall,et al.  Treatment of status epilepticus with lorazepam. , 1984, Archives of neurology.

[17]  M. Aminoff.  Do nonconvulsive seizures damage the brain?--No. , 1998, Archives of neurology.

[18]  C. Martínez,et al.  Fatal ventricular fibrillation following intravenous sodium diphenylhydantoin therapy. , 1967, JAMA.

[19]  M. Privitera,et al.  EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness , 1994, Epilepsy Research.

[20]  D. Labar,et al.  Nonconvulsive Status Epilepticus in the Elderly: A Case Series and a Review of the Literature , 1998 .

[21]  F. Drislane,et al.  Clinical implications of generalized electrographic status epilepticus , 1994, Epilepsy Research.

[22]  P. Despland,et al.  Failure to recall (but not to remember) , 1996, Neurology.

[23]  R. Tasker,et al.  Hippocampal damage produced by systemic injections of domoic acid in mice , 1991, Neuroscience.

[24]  S. I. Lee.  Nonconvulsive Status Epilepticus: Ictal Confusion in Later Life , 1985 .

[25]  M. Mikati,et al.  Protracted Epileptiform Encephalopathy: An Unusual Form of Partial Complex Status Epilepticus , 1985, Epilepsia.

[26]  R. S. Sloviter,et al.  “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology , 1983, Brain Research Bulletin.

[27]  R. Homan,et al.  Lorazepam in status epilepticus , 1979, Annals of neurology.

[28]  P. Kaplan.  Nonconvulsive Status Epilepticus in the Emergency Room , 1996, Epilepsia.

[29]  E. Waterhouse,et al.  Persistent Nonconvulsive Status Epilepticus After the Control of Convulsive Status Epilepticus , 1998, Epilepsia.

[30]  H. Kirshner,et al.  Aphasia secondary to partial status epilepticus of the basal temporal language area , 1995, Neurology.

[31]  F. Drislane.  Nonconvulsive status epilepticus in patients with cancer , 1994, Clinical Neurology and Neurosurgery.

[32]  J. Olney,et al.  Kainic acid: a powerful neurotoxic analogue of glutamate. , 1974, Brain research.

[33]  H. Gastaut,et al.  [The significance of certain epileptic fugues; concerning a clinical and electrical observation of temporal status epilepticus]. , 1956, Revue neurologique.

[34]  F. Drislane.  Evidence against permanent neurologic damage from nonconvulsive status epilepticus. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[35]  B. Uthman,et al.  A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.

[36]  R. S. Sloviter,et al.  “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine , 1985, Brain Research Bulletin.

[37]  A. Gökyiğit,et al.  Diffuse Spike‐Wave Status of 9‐Year Duration Without Behavioral Change or Intellectual Decline , 1995, Epilepsia.

[38]  J. Karliner,et al.  Ventricular standstill after intravenous diphenylhydantoin. , 1967, American heart journal.

[39]  E. So,et al.  Clinical significance and outcome of subclinical status epilepticus in adults , 1995 .

[40]  G. B. Young,et al.  Do nonconvulsive seizures damage the brain?--Yes. , 1998, Archives of neurology.

[41]  D. Hosford,et al.  Animal models of nonconvulsive status epilepticus. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[42]  Anand Kumar,et al.  Intravenous midazolam for the treatment of refractory status epilepticus. , 1992 .

[43]  B. Ludwig,et al.  Prolonged partial complex status epilepticus , 1978, Neurology.

[44]  T. Tomson,et al.  Nonconvulsive Status Epilepticus: High Incidence of Complex Partial Status , 1986, Epilepsia.

[45]  S. Venkataraman,et al.  Diazepam and intubation in emergency treatment of seizures in children. , 1991, Annals of emergency medicine.

[46]  Mark E. Williams,et al.  Impairment of Extrarenal Potassium Disposal by α-Adrenergic Stimulation , 1984 .

[47]  Josemir W Sander,et al.  Complex partial status epilepticus: a recurrent problem. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[48]  A. Shafer.  Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. , 1998, Critical care medicine.

[49]  D M Treiman,et al.  Markedly Increased Mesiotemporal Lobe Metabolism in a Case with PLEDs: Further Evidence that PLEDs are a Manifestation of Partial Status Epilepticus , 1994, Epilepsia.

[50]  T. Henry,et al.  Nonconvulsive Status Epilepticus in the Critically Ill Elderly , 1998, Epilepsia.

[51]  M Ingvar,et al.  Status epilepticus in well–oxygenated rats causes neuronal necrosis , 1985, Annals of neurology.

[52]  R. Fisher,et al.  Complex partial status epilepticus accompanied by serious morbidity and mortality , 1995, Neurology.

[53]  R. S. Sloviter.  “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies , 1983, Brain Research Bulletin.